425 related articles for article (PubMed ID: 10413294)
21. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
22. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
[TBL] [Abstract][Full Text] [Related]
23. Competitive inhibition of photoaffinity labelling of P-glycoprotein by anticancer drugs and modulators including S9788.
Demmer A; Dunn T; Hoof T; Kubesch P; Tümmler B
Eur J Pharmacol; 1996 Nov; 315(3):339-43. PubMed ID: 8982674
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918.
Wallstab A; Koester M; Böhme M; Keppler D
Br J Cancer; 1999 Mar; 79(7-8):1053-60. PubMed ID: 10098736
[TBL] [Abstract][Full Text] [Related]
25. Purification and reconstitution of functional human P-glycoprotein.
Ambudkar SV
J Bioenerg Biomembr; 1995 Feb; 27(1):23-9. PubMed ID: 7629047
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
Park S; Majd S
PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
[TBL] [Abstract][Full Text] [Related]
28. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
[TBL] [Abstract][Full Text] [Related]
29. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity.
Szabó K; Bakos E; Welker E; Müller M; Goodfellow HR; Higgins CF; Váradi A; Sarkadi B
J Biol Chem; 1997 Sep; 272(37):23165-71. PubMed ID: 9287320
[TBL] [Abstract][Full Text] [Related]
31. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
Kim SW; Kwon HY; Chi DW; Shim JH; Park JD; Lee YH; Pyo S; Rhee DK
Biochem Pharmacol; 2003 Jan; 65(1):75-82. PubMed ID: 12473381
[TBL] [Abstract][Full Text] [Related]
32. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells.
Shapiro AB; Ling V
J Biol Chem; 1994 Feb; 269(5):3745-54. PubMed ID: 7906270
[TBL] [Abstract][Full Text] [Related]
33. Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form.
Rebbeor JF; Senior AE
Biochim Biophys Acta; 1998 Feb; 1369(1):85-93. PubMed ID: 9528676
[TBL] [Abstract][Full Text] [Related]
34. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
Ferry D; Boer R; Callaghan R; Ulrich WR
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
[TBL] [Abstract][Full Text] [Related]
35. Characterization of prenylcysteines that interact with P-glycoprotein and inhibit drug transport in tumor cells.
Zhang L; Sachs CW; Fu HW; Fine RL; Casey PJ
J Biol Chem; 1995 Sep; 270(39):22859-65. PubMed ID: 7559420
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo reversal of cancer cell multidrug resistance by the semi-synthetic antibiotic tiamulin.
Baggetto LG; Dong M; Bernaud J; Espinosa L; Rigal D; Bonvallet R; Marthinet E
Biochem Pharmacol; 1998 Nov; 56(9):1219-28. PubMed ID: 9802334
[TBL] [Abstract][Full Text] [Related]
37. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
Ambudkar SV; Lelong IH; Zhang J; Cardarelli CO; Gottesman MM; Pastan I
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8472-6. PubMed ID: 1356264
[TBL] [Abstract][Full Text] [Related]
38. Purification and reconstitution of human P-glycoprotein.
Ambudkar SV; Lelong IH; Zhang J; Cardarelli C
Methods Enzymol; 1998; 292():492-504. PubMed ID: 9711577
[TBL] [Abstract][Full Text] [Related]
39. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
Broxterman HJ; Sonneveld P; Feller N; Ossenkoppele GJ; Währer DC; Eekman CA; Schoester M; Lankelma J; Pinedo HM; Löwenberg B; Schuurhuis GJ
Blood; 1996 Jun; 87(11):4809-16. PubMed ID: 8639853
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
Sharom FJ; Yu X; Chu JW; Doige CA
Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):381-90. PubMed ID: 7772017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
